Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Velcade with chemotherapy in relapsed/refractory ALL
NCT00440726Phase 2Completed
- Sponsor
- Therapeutic Advances in Childhood Leukemia and Lymphoma Consortium
- Start
- Aug 2006
- Primary completion
- Feb 2011
- Modality
- Small Molecules, Modified Peptides
- Countries
- 4
01
Overview
A Phase 2 trial of bortezomib in acute lymphoblastic leukemia (ALL), sponsored by Therapeutic Advances in Childhood Leukemia and Lymphoma Consortium. Started Aug 2006; status: completed.
02
Drugs
bortezomib
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT00440726.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00440726.